PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
Clinical trials for PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA trials appear
Sign up with your email to follow new studies for PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Promising new drug TURALIO tested in kids with tough cancers
Disease control Recruiting nowThis early-stage study tests a drug called TURALIO (pexidartinib) in people aged 3 to 35 whose cancer (like leukemia or solid tumors) has not responded to standard treatments. The main goal is to find a safe dose and see if it can shrink tumors or stop them from growing. Particip…
Matched conditions: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 05:43 UTC
-
Engineered immune cells take on tough blood cancers in early trial
Disease control Recruiting nowThis early-phase study tests a personalized cell therapy called CART123 in 18 adults with certain blood cancers (like acute myeloid leukemia) that have not responded to standard treatments. Each patient's own immune cells are modified in a lab to recognize and attack cancer cells…
Matched conditions: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
Phase: EARLY_PHASE1 • Sponsor: Institute of Hematology and Blood Transfusion, Czech Republic • Aim: Disease control
Last updated May 26, 2026 04:38 UTC
-
New hope for leukemia patients: gentler chemo plus immunotherapy shows promise
Disease control Recruiting nowThis study tests a combination of low-dose chemotherapy and immune-targeted drugs for adults newly diagnosed with a specific type of leukemia (Ph-negative B-cell acute lymphoblastic leukemia). The goal is to see if this gentler approach can help more patients achieve a deep remis…
Matched conditions: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
Phase: PHASE2 • Sponsor: Institute of Hematology & Blood Diseases Hospital, China • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New hope for young leukemia patients: immune cell therapy trial launches
Disease control Recruiting nowThis early-stage trial tests a new type of immune cell therapy (CART cells) for children, teens, and young adults with leukemia that has come back or not responded to standard treatments. The study aims to see if making these special cells in the lab is possible and safe. About 1…
Matched conditions: PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA
Phase: PHASE1 • Sponsor: Instituto de Investigación Hospital Universitario La Paz • Aim: Disease control
Last updated May 20, 2026 11:56 UTC